Docetaxel (DTX) and carboplatin (CP) followed by a dose-ranging study of oral capecitabine, weekly DTX, concomitant radiotherapy and surgery for the treatment of patients with stage II-III carcinoma of the esophagus
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. A. Bubis, I. Williams, K. H. Dragnev, J. E. Sutton, S. R. Gordon, B. I. Zaki, B. F. Cole, J. R. Rigas
Institution: Dartmouth–Hitchcock Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2243292644